Gianluca Sambataro

Fixed-term Assistant Professor (RTDB) of RHEUMATOLOGY [MED/16]

Classic High School diploma in 2002 at the Lucia Mangano Institute in S. Giovanni La Punta, (CT), in 2002; Medical Degree in Campus Bio-Medico University of Rome in 2009 ; Postgraduation in Allergology and Clinical Immunology in Campus Bio-Medico University of Rome in 2015 ; II level Master degree entitled « clinical problem solving in Rheumatology) IN Unicusano University of Rome (RM) in 2017. Winner of scholarship with the italina Society of Rheumatology with the project « multidisciplinary collaboration between rheumatologists and pulmonologists in the assessment of patients with Interstitial lung Diseases », conducted in the University of Catania in 2017. Research Grant type B sector MED/10 entitled « Rôle of RAS/ERK and MET pathways on fibroblast activation and differentiation »  with the University of Catania, from 2018 to 2023. Physician in Department of Clinical and Experimental Medicine, Unit of Respiratory Diseases, « Policlinico G.Rodolico-San Marco » in 2020.

N.B. the number of publications can affect the loading time of the information

Interstitial Lung Disease associated with Autoimmune conditions, with particular interest in Interstitial Pneumonia with Autommune Features (IPAF) and Idiopathic Inflammatory Myopathies (Dermatomyositis and Antisynthetase Syndrome).


Interstitial Lung Disease; Interstitial Pneumonia with Autoimmune Features, Idiopathic Inflammatory Myopathies; Dermatomyositis; Antisynthetase Syndrome; Systemic Sclerosis; Rheumatoid Arthritis; Progressive-Fibronsing-ILD; 

Associate Editor of BMC Pulmonary Medicine; Guest Editor for Frontiers in Medicine and Diagnostics (Basel) ; revwiever for the majority of Q1 and Q2 journals of Respiratory Medicine and Rheumatology, Winner of Scholarship with the Italian Society of Rheumatology in 2016 ; author of three chapters in book edited by Elsevier (Eosinophilic Interstitial Pneumonia nel 2020; Translational Autoimmunity volume 3, Autoimmune Disease associated with different clinical features, chapter Translational Autoimmunity in Interstitial Lung Disease 2021; Developing PI3K inhibitors for respiratory diseases. Springer, 2022.). Since March 2023 author of 80 publications indexed in Pubmed, Scopus, Web of Science.